1-7 of 7
Max Solenthaler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Programmed death 1 signaling on chronic myeloid leukemia–specific T cells results in T-cell exhaustion and disease progression

Sabine Mumprecht, Christian Schürch, Juerg Schwaller, Max Solenthaler, Adrian F. Ochsenbein
Journal: Blood
Blood (2009) 114 (8): 1528–1536.
https://doi.org/10.1182/blood-2008-09-179697
Published: 2009
Journal Articles

The Combination of 2-CDA and Rituximab in Patients with Chronic Lymphocytic Leukemia (CLL): A Prospective Multicenter Phase II Trial (SAKK 34/02).

Nicolas Leupin, MD, Jan C. Schuller, PhD, Max Solenthaler, MD, Andre Tichelli, MD, Alois Gratwohl, MD, Kurt Beretta, MD, Mario J. Bargetzi, MD, Andreas Himmelmann, MD, Susanne Hanselmann, PhD, Reinhard Zenhausern, MD
Journal: Blood
Blood (2007) 110 (11): 2057.
https://doi.org/10.1182/blood.V110.11.2057.2057
Published: 2007
Journal Articles

PD-1 Signaling on Chronic Myeloid Leukemia-Specific T Cells Results in T Cell Exhaustion and Disease Progression.

Sabine Mumprecht, PhD, Juerg Schwaller, Max Solenthaler, Adrian F. Ochsenbein
Journal: Blood
Blood (2007) 110 (11): 2923.
https://doi.org/10.1182/blood.V110.11.2923.2923
Published: 2007
Journal Articles

A Randomized Study of Daily Versus Weekly Administration of 2-Chlorodeoxyadenosine in Patients with Hairy Cell Leukemia.

Reinhard Zenhausern, MD, Nicolas Leupin, Shu-Fang Hsu Schmitz, Max Solenthaler, Andre Tichelli, Dominik Heim, Urs Hess, Leda Leoncini, Mario Bargetzi, Andreas Tobler
Journal: Blood
Blood (2007) 110 (11): 1352.
https://doi.org/10.1182/blood.V110.11.1352.1352
Published: 2007
Journal Articles

Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia

Clinical Trials & Observations
Rüdiger Hehlmann, Ute Berger, Markus Pfirrmann, Hermann Heimpel, Andreas Hochhaus, Joerg Hasford, Hans-Jochem Kolb, Tanja Lahaye, Ole Maywald, Andreas Reiter, Dieter K. Hossfeld, Christoph Huber, Helmut Löffler, Hans Pralle, Wolfgang Queisser, Andreas Tobler, Christoph Nerl, Max Solenthaler, Mariele E. Goebeler, Martin Griesshammer, Thomas Fischer, Stephan Kremers, Hartmut Eimermacher, Michael Pfreundschuh, Wolf-Dietrich Hirschmann, Klaus Lechner, Barbara Wassmann, Christiane Falge, Hartmut H. Kirchner, Alois Gratwohl
Journal: Blood
Blood (2007) 109 (11): 4686–4692.
https://doi.org/10.1182/blood-2006-11-055186
Published: 2007
Includes: Supplemental data
Journal Articles

Acquired Deficiency of von Willebrand Factor-Cleaving Protease in a Patient With Thrombotic Thrombocytopenic Purpura

Miha Furlan, Rodolfo Robles, Max Solenthaler, Bernhard Lämmle
Journal: Blood
Blood (1998) 91 (8): 2839–2846.
https://doi.org/10.1182/blood.V91.8.2839.2839_2839_2846
Published: 1998
Journal Articles

Deficient Activity of von Willebrand Factor–Cleaving Protease in Chronic Relapsing Thrombotic Thrombocytopenic Purpura

Miha Furlan, Rodolfo Robles, Max Solenthaler, Max Wassmer, Pierre Sandoz, Bernhard Lämmle
Journal: Blood
Blood (1997) 89 (9): 3097–3103.
https://doi.org/10.1182/blood.V89.9.3097
Published: 1997